Life Sciences Times

TRIANA Biomedicines Secures FDA Fast Track Status for Lung Cancer Therapy TRI-611

Study Links Obesity to Cancer Risk Through Organ Growth and Increased Cell Counts

Artis BioSolutions Expands U.S. Manufacturing With Boston Synthetic DNA Hub

argenx Expands Use of eClinical Solutions’ elluminate Platform to Boost Trial Data Efficiency

Amylyx Completes Enrollment in Phase 3 Trial of Avexitide for Post-Bariatric Hypoglycemia

Alnylam Expands Efforts to Improve ATTR-CM Diagnosis and Care Through Strategic Partnerships

eGenesis Tops Fast Company’s 2026 Most Innovative Biotech List, Ranks No. 34 Overall

Cellino Named to Fast Company’s 2026 List of World’s Most Innovative Companies

Thermo Fisher Closes $8.9 Billion Clario Acquisition to Boost Clinical Trial Capabilities

Oryon Cell Therapies Emerges From Stealth With $42 Million in Funding, Appoints Ron Cohen, M.D., as CEO